Literature DB >> 10944805

Immunostimulatory DNA sequences and cancer therapy.

G J Weiner1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10944805     DOI： 10.1007/s002810000022

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


× No keyword cloud information.
  58 in total

1.  Tumor-specific, cytotoxic T-lymphocyte response after idiotype vaccination for B-cell, non-Hodgkin's lymphoma.

Authors:  E L Nelson; X Li; F J Hsu; L W Kwak; R Levy; C Clayberger; A M Krensky
Journal:  Blood       Date:  1996-07-15       Impact factor: 22.113

2.  Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA.

Authors:  T Jakob; P S Walker; A M Krieg; M C Udey; J C Vogel
Journal:  J Immunol       Date:  1998-09-15       Impact factor: 5.422

3.  CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: a new class of vaccine adjuvants.

Authors:  G B Lipford; M Bauer; C Blank; R Reiter; H Wagner; K Heeg
Journal:  Eur J Immunol       Date:  1997-09       Impact factor: 5.532

4.  Dendritic cells hold promise for immunotherapy.

Authors:  G Girolomoni; P Ricciardi-Castagnoli
Journal:  Immunol Today       Date:  1997-03

5.  Immunotherapy using dendritic cells picks up steam.

Authors:  J McCann
Journal:  J Natl Cancer Inst       Date:  1997-04-16       Impact factor: 13.506

6.  From dendritic cells to tumour vaccines.

Authors:  T J Hamblin
Journal:  Lancet       Date:  1996-03-16       Impact factor: 79.321

7.  Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA.

Authors:  Z K Ballas; W L Rasmussen; A M Krieg
Journal:  J Immunol       Date:  1996-09-01       Impact factor: 5.422

8.  A recombinant vaccinia virus expressing human prostate-specific antigen (PSA): safety and immunogenicity in a non-human primate.

Authors:  J W Hodge; J Schlom; S J Donohue; J E Tomaszewski; C W Wheeler; B S Levine; L Gritz; D Panicali; J A Kantor
Journal:  Int J Cancer       Date:  1995-10-09       Impact factor: 7.396

9.  Antimetastatic activity induced by Clostridium butyricum and characterization of effector cells.

Authors:  H Y Chen; S L Wu; M Y Yeh; C F Chen; Y Mikami; J S Wu
Journal:  Anticancer Res       Date:  1993 Jan-Feb       Impact factor: 2.480

Review 10.  Tissue distribution and tumor localization of effector cells in adoptive immunotherapy of cancer.

Authors:  P H Basse
Journal:  APMIS Suppl       Date:  1995
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.